E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 6
7 / 6Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Review Article

Online Publishing Date:
07 / 06 / 2021

 


Dobesilate an old drug as a possible new treatment option for COVID-19 infection

Pedro Cuevas, Javier Angulo, Daniel Zingg, Antonio Manquillo, José Luis Calleja, Guillermo Giménez-Gallego.


Abstract
COVID-19 pandemic is responsible for near to two million deaths worldwide. Because of the lack of any specific treatment option, repurposing of existing drugs continues worldwide in order to find immediate therapeutic strategies for deadly SARS-CoV-2 infection. We recently demonstrated the efficacy of Dobesilate, an old medicament with a long history of use with proven efficacy and good safety profiles, in a patient suffering from COVID-19 disease. The postulated therapeutic mechanism of Dobesilate in COVID-19 disease may primarily involve the following effects: reducing infection-related pathways, suppressing inflammation-related pathways (cytokine storm), protecting capillary barrier permeability, alleviating thrombosis and perivascular oedema, and ultimately attenuating interstitial fibrosis.

Key words: SARS-CoV-2, COVID-19, Dobesilate, FGF, VEGF


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedro Cuevas
Articles by Javier Angulo
Articles by Daniel Zingg
Articles by Antonio Manquillo
Articles by José Luis Calleja
Articles by Guillermo Giménez-Gallego
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cuevas P, Angulo J, Zingg D, Manquillo A, Calleja JL, Giménez-Gallego G. Dobesilate an old drug as a possible new treatment option for COVID-19 infection. Int J Med Rev Case Rep. 2021; 5(5): 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19

Web Style

Cuevas P, Angulo J, Zingg D, Manquillo A, Calleja JL, Giménez-Gallego G. Dobesilate an old drug as a possible new treatment option for COVID-19 infection. https://www.mdpub.net/?mno=85175 [Access: April 04, 2024]. doi:10.5455/IJMRCR.dobesilate-covid-19

AMA (American Medical Association) Style

Cuevas P, Angulo J, Zingg D, Manquillo A, Calleja JL, Giménez-Gallego G. Dobesilate an old drug as a possible new treatment option for COVID-19 infection. Int J Med Rev Case Rep. 2021; 5(5): 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


Vancouver/ICMJE Style

Cuevas P, Angulo J, Zingg D, Manquillo A, Calleja JL, Giménez-Gallego G. Dobesilate an old drug as a possible new treatment option for COVID-19 infection. Int J Med Rev Case Rep. (2021), [cited April 04, 2024]; 5(5): 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


Harvard Style

Cuevas, P., Angulo, . J., Zingg, . D., Manquillo, . A., Calleja, . J. L. & Giménez-Gallego, . G. (2021) Dobesilate an old drug as a possible new treatment option for COVID-19 infection. Int J Med Rev Case Rep, 5 (5), 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


Turabian Style

Cuevas, Pedro, Javier Angulo, Daniel Zingg, Antonio Manquillo, José Luis Calleja, and Guillermo Giménez-Gallego. 2021. Dobesilate an old drug as a possible new treatment option for COVID-19 infection. International Journal of Medical Reviews and Case Reports, 5 (5), 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


Chicago Style

Cuevas, Pedro, Javier Angulo, Daniel Zingg, Antonio Manquillo, José Luis Calleja, and Guillermo Giménez-Gallego. "Dobesilate an old drug as a possible new treatment option for COVID-19 infection." International Journal of Medical Reviews and Case Reports 5 (2021), 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


MLA (The Modern Language Association) Style

Cuevas, Pedro, Javier Angulo, Daniel Zingg, Antonio Manquillo, José Luis Calleja, and Guillermo Giménez-Gallego. "Dobesilate an old drug as a possible new treatment option for COVID-19 infection." International Journal of Medical Reviews and Case Reports 5.5 (2021), 113-121. Print. doi:10.5455/IJMRCR.dobesilate-covid-19


APA (American Psychological Association) Style

Cuevas, P., Angulo, . J., Zingg, . D., Manquillo, . A., Calleja, . J. L. & Giménez-Gallego, . G. (2021) Dobesilate an old drug as a possible new treatment option for COVID-19 infection. International Journal of Medical Reviews and Case Reports, 5 (5), 113-121. doi:10.5455/IJMRCR.dobesilate-covid-19


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500